NDC 21130-907-01 - NIGHTTIME CHERRY COLD AND FLU
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 21130-907
- Requested NDC
- 21130-907-01
- Package NDCs from labels
- 21130-907-01, 21130-907-02, 21130-907-06
- Manufacturer
- BETTER LIVING BRANDS LLC. | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2026-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN - BETTER LIVING BRANDS LLC. | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | BETTER LIVING BRANDS LLC. | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2026-03-03 | HUMAN OTC DRUG LABEL |
| 773L-Albertsons- Daytime and Nighttime Cold & Flu Liquid | BETTER LIVING BRANDS, LLC | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2025-06-28 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21130-907-01 | NIGHTTIME CHERRY COLD AND FLU | 354 mL in 1 BOTTLE | LIQUID | 354 | 2 | |
| 21130-907-02 | NIGHTTIME CHERRY COLD AND FLU | 2 in 1 PACKAGE | LIQUID | 2 | 2 | |
| 21130-907-06 | NIGHTTIME CHERRY COLD AND FLU | 236 mL in 1 BOTTLE | LIQUID | 236 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hand Sanitizing Wipes | HAND SANITIZING WIPES | Innovative Biodefense | b01d3c2c-056c-314c-e053-2a95a90a42f4 | 2023-09-16 | Warnings | 3K9958V90M |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | Eugia US LLC | 303bc1e6-0735-4ea1-84cd-6c1b621de0ed | 2023-09-16 | Warnings, Adverse reactions | 04JA59TNSJ |
| Epiforce P-HP | ARSENICUM ALBUM, BORAX, GRAPHITES, NATRUM MURIATICUM, SEPIA, SULPHUR | BioActive Nutritional, Inc. | 250441d1-e261-417e-9100-700368ea38fd | 2023-09-11 | Warnings | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | a9910e09-5aea-4ee1-a35e-ae4abf8b80b4 | 2023-09-07 | Warnings, Adverse reactions | 451W47IQ8X |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 6DC9Q167V3 PDC6A3C0OX 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 6DC9Q167V3 PDC6A3C0OX 059QF0KO0R XF417D3PSL |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | OJ245FE5EU |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R H3R47K3TBD |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R TTV12P4NEE |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R TTV12P4NEE |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 6DC9Q167V3 059QF0KO0R 3K9958V90M |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R TTV12P4NEE |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 6DC9Q167V3 PDC6A3C0OX 059QF0KO0R 3K9958V90M |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 6DC9Q167V3 PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 6DC9Q167V3 PDC6A3C0OX 059QF0KO0R 3K9958V90M |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 6DC9Q167V3 PDC6A3C0OX 059QF0KO0R 3K9958V90M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.